BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $57,000 | -24.0% | 57,000 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $75,000 | +23.0% | 57,000 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $61,000 | -1.6% | 57,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $62,000 | +6.9% | 57,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $58,000 | -10.8% | 57,000 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $65,000 | -7.1% | 57,000 | 0.0% | 0.01% | -53.3% |
| Q2 2018 | $70,000 | – | 57,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |